{"transactions":[{"id":747538,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T21:09:02.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":5368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":5368,"derivative":{"exercise_price":15.74,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":5368},"source":{"system":"sec-edgar","filing":"0001595202-26-000002","document":"wk-form4_1780693739.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000159520226000002/wk-form4_1780693739.xml","form_type":"4"}},{"id":747537,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T21:09:02.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":2890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares shall vest in twelve (12) equal consecutive monthly installments until all of the shares are fully vested, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":2890,"source":{"system":"sec-edgar","filing":"0001595202-26-000002","document":"wk-form4_1780693739.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000159520226000002/wk-form4_1780693739.xml","form_type":"4"}},{"id":1117494,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T21:25:31.000Z","date":"2025-06-06","kind":"grant","planned":false,"acquired":true,"shares":8745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable, subject to the Reporting Person's continuous service through each vesting date."}],"balance_after":8745,"derivative":{"exercise_price":13.15,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":8745},"source":{"system":"sec-edgar","filing":"0001415889-25-016324","document":"form4-06092025_050601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588925016324/form4-06092025_050601.xml","form_type":"4"}},{"id":1483061,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Rt to Buy)","published_at":"2024-06-11T20:18:55.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":17774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":17774,"derivative":{"exercise_price":6.47,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":17774},"source":{"system":"sec-edgar","filing":"0001415889-24-016362","document":"form4-06112024_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000141588924016362/form4-06112024_080652.xml","form_type":"4"}},{"id":1855556,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Rt to Buy)","published_at":"2023-06-14T21:00:07.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":27380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":27380,"derivative":{"exercise_price":4.2,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":27380},"source":{"system":"sec-edgar","filing":"0001209191-23-037078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919123037078/doc4.xml","form_type":"4"}},{"id":2224998,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-22T01:13:37.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":18253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable."}],"balance_after":18253,"derivative":{"exercise_price":6.3,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":18253},"source":{"system":"sec-edgar","filing":"0001209191-22-038617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919122038617/doc4.xml","form_type":"4"}},{"id":2528274,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-03T00:49:53.000Z","date":"2021-11-01","kind":"grant","acquired":true,"shares":11836,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest in equal monthly installments commencing December 1, 2021"}],"balance_after":11836,"derivative":{"exercise_price":15.63,"expiration_date":"2031-10-31","underlying":"Common Stock","underlying_shares":11836},"source":{"system":"sec-edgar","filing":"0001209191-21-062569","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1528287/000120919121062569/doc4.xml","form_type":"4"}},{"id":4497403,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":1500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497402,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":18844,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":61.62,"exercise_date":"2016-12-17","expiration_date":"2023-12-07","underlying":"Common Stock","underlying_shares":18844},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497401,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":872,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":872},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497400,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":15380,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":69.08,"exercise_date":"2015-12-17","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":15380},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497399,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":1315,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, each unvested restricted stock unit was assumed by Abbott and converted into restricted stock units for the number of shares of Abbott Common Stock equal to the product (rounded to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such restricted stock unit immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1315},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497398,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":14668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each option provided for vesting in four equal installments on December 17 commencing on the date shown in the table.  Pursuant to the Merger Agreement, the vested options were treated as set forth in note (2).  The unvested options were assumed by Abbott and converted into an option to acquire the number of shares of Abbott Common Stock equal to the product (rounded down to the nearest whole share) of (i) the number of shares of Issuer Common Stock subject to such option immediately prior to the Mergers multiplied by (ii) the Stock Award Exchange Ratio (as defined in the Merger Agreement), at an exercise price per share of Abbott stock equal to the quotient (rounded up to the nearest whole cent) of (A) the per share exercise price for the shares of Issuer Common Stock subject to such option immediately prior to the Mergers divided by (B) the Stock Award Exchange Ratio."}],"balance_after":0,"derivative":{"exercise_price":59.41,"exercise_date":"2014-12-17","expiration_date":"2021-12-10","underlying":"Common Stock","underlying_shares":14668},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497397,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":15284,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":35.27,"exercise_date":"2013-12-17","expiration_date":"2020-12-10","underlying":"Common Stock","underlying_shares":15284},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497396,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":9332,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":34.96,"exercise_date":"2012-12-17","expiration_date":"2019-12-12","underlying":"Common Stock","underlying_shares":9332},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497395,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":6664,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":41.65,"exercise_date":"2011-12-14","expiration_date":"2018-12-14","underlying":"Common Stock","underlying_shares":6664},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497394,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":6050,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the terms of the Merger Agreement, each option that was fully vested and exercisable immediately prior to the Mergers was deemed exercised pursuant to a cashless exercise and settled by issuance of a number of shares of Issuer Common Stock (\"Net Exercise Shares\") equal to the excess (rounded down to the nearest whole share, but with any partial shares otherwise issuable settled in cash) of (i) the number of Issuer shares of Common Stock subject to such option immediately prior to the Mergers over (ii) the number of whole and partial (computed to the nearest four decimal places) Issuer shares of Common Stock that, when multiplied by the Company equity plan-defined FMV, is equal to the aggregate exercise price of the exercised options. Each Net Exercise Share was then canceled and converted into the right to receive the Merger Consideration, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":38.59,"exercise_date":"2010-12-14","expiration_date":"2017-12-14","underlying":"Common Stock","underlying_shares":6050},"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4497393,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2017-01-06T13:56:05.000Z","date":"2017-01-04","kind":"disposition_to_issuer","acquired":false,"shares":10302,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the terms of the Agreement and Plan of Merger, dated April 27, 2016, by and among Abbott Laboratories (\"Abbott\"), the Issuer, Vault Merger Sub, Inc. and Vault Merger Sub, LLC (the \"Merger Agreement\"), each share of Issuer Common Stock was cancelled in exchange for $46.75 in cash and 0.8708 of a share of Abbott Common Stock (the \"Merger Consideration\"), less any applicable withholding taxes, and provided that cash is payable in respect of any fractional shares of Abbott stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-000617","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911017000617/edgar.xml","form_type":"4"}},{"id":4516202,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":1500,"derivative":{"exercise_date":"2016-12-17","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516201,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":872,"derivative":{"exercise_date":"2015-12-17","underlying":"Common Stock","underlying_shares":1308},"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516200,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":1315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":1315,"derivative":{"exercise_date":"2014-12-17","underlying":"Common Stock","underlying_shares":2630},"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516199,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":false,"shares":477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units will vest 25% on December 17th annually beginning the date shown."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":0,"derivative":{"exercise_date":"2013-12-17","underlying":"Common Stock","underlying_shares":477},"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516198,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":138,"price":79.2,"value":10929.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"500 shares of restricted stock vested on December 17, 2016. 138 shares were used to pay taxes and 362 shares were released."}],"balance_after":10302,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516197,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":10440,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516196,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":120,"price":79.2,"value":9504.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"436 shares of restricted stock vested on December 17, 2016. 120 shares were used to pay taxes and 316 shares were released."}],"balance_after":9940,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516195,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":436,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":10060,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516194,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":363,"price":79.2,"value":28749.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"1,315 shares of restricted stock vested on December 17, 2016. 363 shares were used to pay taxes and 952 shares were released."}],"balance_after":9624,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516193,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":1315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":9987,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516192,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"tax_withholding","acquired":false,"shares":132,"price":79.2,"value":10454.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"477 shares of restricted stock vested on December 17, 2016. 132 shares were used to pay taxes and 345 shares were released."}],"balance_after":8672,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4516191,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-20T16:34:27.000Z","date":"2016-12-17","kind":"exercise","acquired":true,"shares":477,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."}],"balance_after":8804,"source":{"system":"sec-edgar","filing":"0001179110-16-033294","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033294/edgar.xml","form_type":"4"}},{"id":4518045,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2016-12-19T16:07:38.000Z","date":"2016-12-15","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested at the time of filing."}],"balance_after":0,"derivative":{"exercise_price":30.58,"exercise_date":"2009-12-15","expiration_date":"2016-12-15","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001179110-16-033189","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033189/edgar.xml","form_type":"4"}},{"id":4518044,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-19T16:07:38.000Z","date":"2016-12-15","kind":"tax_withholding","acquired":false,"shares":828,"price":79.88,"value":66140.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock withheld to pay the exercise price of the stock options and to pay tax withholdings.  The 1,500 shares acquired upon the option exercise, net of 828 shares used to pay exercise price and taxes, resulted in 672 shares that were retained."}],"balance_after":8327,"source":{"system":"sec-edgar","filing":"0001179110-16-033189","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033189/edgar.xml","form_type":"4"}},{"id":4518043,"issuer":{"id":179857,"kind":"organization","name":"ST JUDE MEDICAL, LLC","symbol":"STJ"},"owners":[{"id":40816,"kind":"person","name":"Andrade Lisa","position":1,"cik":"0001595202","reported_name":"Andrade Lisa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Marketing Officer"}}],"security":"Common Stock","published_at":"2016-12-19T16:07:38.000Z","date":"2016-12-15","kind":"exercise","acquired":true,"shares":1500,"price":30.58,"value":45870.0,"ownership":{"direct":true},"balance_after":9155,"source":{"system":"sec-edgar","filing":"0001179110-16-033189","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/203077/000117911016033189/edgar.xml","form_type":"4"}}]}